PharVision Advisers’s Walmart Inc WMT Stock Holding History

PharVision Advisers’s Portfolio WMT Stock Details WMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,150	Closed	-$574K	–	653
2025 Q4	$574K	Buy	5,150 +3,180	+161%	+$341K	0.29%	18
2025 Q3	$203K	Buy	+1,970	New	+$196K	0.11%	505

Other funds holding WMT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's WMT Position: Q1 2026 in Review

PharVision Advisers sold out of Walmart Inc (WMT) in Q1 2026, closing a stake of 5,150 shares — an estimated $574K sold.

PharVision Advisers first reported a position in WMT in Q3 2025 and held it in 2 quarters. The position peaked at $574K in Q4 2025. 4,424 funds tracked by Wall St. Rank hold WMT as of Q1 2026.

PharVision Advisers reported no remaining Walmart Inc position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 5,150 Walmart Inc shares in Q1 2026, an estimated $574K.
PharVision Advisers first reported a position in Walmart Inc in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Walmart Inc position peaked at $574K in Q4 2025.
4,424 funds tracked by Wall St. Rank held Walmart Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.